Evidence map›Paper›PMID 18555914›Full record

ReviewLancet (London, England)2008

Tobacco addiction.

Dorothy K Hatsukami, Lindsay F Stead, Prakash C Gupta

3 registry-linked trialsAbstract readReview
In one paragraph

Review in Lancet (London, England), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 90 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01303081 nacompletednot on this mapstarted 2011, after this paper: background citation

Financial Incentive Structures for Smoking Cessation: A Pilot Randomized Trial

TypeinterventionalSponsorUniversity of PennsylvaniaRan2011 to 2012Enrolled63ConditionsTobacco Use DisorderArmsIndividual Rewards, Fixed Deposits, Chosen Deposits, Competitive Deposits (Pari-Mutuel), Usual Care
NCT01362959 phase4completednot on this mapstarted 2012, after this paper: background citation

Nicotine Replacement Therapy in the Intensive Care Unit: a Randomized, Controlled Pilot Study

TypeinterventionalSponsorGelderse Vallei HospitalRan2012 to 2016Enrolled47ConditionsDelirium, Psychomotor Agitation, Substance Withdrawal Syndrome, Nicotine Replacement TherapyArmsTransdermal nicotine patch, Cutaneous patch, containing no active substances
NCT01526265 nacompletednot on this mapstarted 2012, after this paper: background citation

Way to Quit - Comparative Efficacy, Acceptance and Effectiveness of Health Incentive Structures

TypeinterventionalSponsorUniversity of PennsylvaniaRan2012 to 2015Enrolled2,185ConditionsTobacco Use DisorderArmsUsual Care, Individual Rewards, Fixed Deposits, Competitive Deposits (Pari-Mutuel), Collaborative Rewards
3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Nicotinic receptors in airway disease.American journal of physiology. Lung cellular and molecular physiology · 2024
    Review
  18. Review
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Dorothy K HatsukamiUniversity of Minnesota, Comprehensive Cancer Center and Psychiatry, Minneapolis, Minnesota, USA. hatsu001@umn.edu
Lindsay F Stead
Prakash C Gupta

Funding

TOBACCO REDUCTION STRATEGIES FOR PATIENTS WITH CARDIAC DISEASEP50DA013333 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HATSUKAMI, DOROTHY K · 1999 to 2008
$16.8M
NIDA NIH HHS P50 DA013333
6 · The paper itself

Abstract

Tobacco use is associated with 5 million deaths per year worldwide and is regarded as one of the leading causes of premature death. Comprehensive programmes for tobacco control can substantially reduce the frequency of tobacco use. An important component of a comprehensive programme is the provision of treatment for tobacco addiction. Treatment involves targeting several aspects of addiction including the underlying neurobiology and behavioural processes. Furthermore, building an infrastructure in health systems that encourages and helps with cessation, as well as expansion of the accessibility of treatments, is necessary. Although pharmacological and behavioural treatments are effective in improving cessation success, the rate of relapse to smoking remains high, emphasising the strong addictive nature of nicotine. The future of treatment resides in improvement in patient matching to treatment, combination or novel drugs, and viewing nicotine addiction as a chronic disorder that might need long-term treatment.

Indexed as

SmokingTobacco Use DisorderCounselingFemaleHumansMaleNicotineNicotinic AgonistsPhysician's RolePrevalenceSmoking CessationNicotineNicotinic Agonists

Identifiers

PMID18555914
PMCPMC4732578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.